2m 2m 2m 2m 2m 2m 2m
THERIVA BIO (TOVX)
NYSE
$0.23-$0.004 (-1.71%)
Price as of Jul 14, 2026 6:42 AM EDT- $10.7MMarket Cap
- -52.92%1-Year Change
- BiotechnologyIndustry
THERIVA BIO (TOVX)
$0.23-$0.004 (-1.71%)
TOVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.23 | ||
Change | -$0.008 (-3.27%) | ||
Open | $0.23 | ||
High | $0.24 | ||
Low | $0.23 | ||
Previous Close | $0.24 | ||
Volume | 487,055 | ||
30-Day Average Volume | 3,028,921 | ||
1-Week Change | -7.62% | ||
1-Month Change | -22.98% | ||
1-Year Change | -52.92% | ||
3-Year Change | -98.72% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.9M | ||
Total Assets | $38.2M | ||
Market Cap | $10.7M | ||
Enterprise Value | -$2.0M | ||
Period: QTR TTM FY | |||
Revenue | $300,000.00 | ||
Net Income | -$2.0M | ||
Free Cash Flow | -$2.5M | ||
EBIT | -$2.0M | ||
EBITDA | -$2.0M | ||
Net Working Capital | $6.5M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -7 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/27/2007 | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/26/2024 | ||
Earnings & Revenue